Erythromycin Lactobionate

   
Google
 
Web NewDrugInformation.com

Erythromycin Lactobionate


Drug - Erythromycin Lactobionate
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Erythromycin Lactobionate
Multiple ingredients are in alphabetical order.

Strength - EQ 1GM BASE/VIAL
The potency of the active ingredient(s), Erythromycin Lactobionate. May repeat for multiple part products.

Applicant - BAXTER HLTHCARE
The firm name holding legal responsibility for Erythromycin Lactobionate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 062993
The FDA assigned number to Erythromycin Lactobionate. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Erythromycin Lactobionate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 9, 1989
The date Erythromycin Lactobionate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Erythromycin Lactobionate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Erythromycin Lactobionate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Baxter Healthcare Corp Anesthesia And Critical Care
The full name of the firm holding legal responsibility for the new application of Erythromycin Lactobionate.

Erythromycin Lactobionate